Accelmed Partners-backed MedMinder appoints Chairman of Board of Directors
MedMinder Systems, a fully integrated, end-to-end pharmacy, medication adherence and connected care solution for elderly and polypharmacy patients backed by private equity firm Accelmed Partners, has appointed David J Shulkin, MD as Chairman of the Board of Directors.
A well-respected American physician and government official, Shulkin previously served as US Secretary of Veterans Affairs and Under Secretary of Veterans Affairs for Health in the Trump and Obama Administrations, respectively. Dr Shulkin also held numerous executive roles at Morristown Medical Center, Atlantic Health System, Beth Israel Medical Center, Temple University Hospital, Drexel University School of Medicine, Medical College of Pennsylvania and University of Pennsylvania Health System. Dr. Shulkin has been named one of the Top 100 Physician Leaders of Hospitals and Health Systems by Becker's Hospital Review and one of the 50 Most Influential Physician Executives in the Country by Modern Healthcare and Modern Physician.
“We are pleased to welcome David to the Board and are confident that his unparalleled experience across the medical and public health fields will be highly valuable to our rapidly growing Company and network of stakeholders,” says Eran Shavelsky, founder and CEO of MedMinder. “David’s appointment signifies an inflection point in MedMinder’s maturation, and we look forward to leveraging his expertise as we continue to expand our business and enhance the patient, clinician and pharmacy experience.”
Dr Shulkin says: “I am honoured to lead the Board of MedMinder, an outstanding and innovative Company deeply committed to improving the lives of chronically ill and elderly patients through innovative pharmacy and remote monitoring solutions. Eran has set a solid foundation for the Company and I am excited to work with him and my fellow directors to increase MedMinder’s customer and technology-enabled solutions for years to come.”
Dr Rafael Torgovicky, General Partner at Accelmed Partners, a lead investor in MedMinder, says: “David’s distinguished career, dedication to patient safety and real expertise in advancing quality of care will serve MedMinder well as we continue to execute on the Company’s growth strategy across the US.”